BioNTech

biontech-advances-dualitybio-adc-into-phase-3-with-half-the-patients-of-merck-daiichi-rival

BioNTech Biotechnology Uncategorized

BioNTech advances DualityBio ADC into phase 3 with half the patients of Merck-Daiichi rival

Feb 27, 2026

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a...

biontech-fades-out-further-work-with-cancer-vaccine-prospect-in-late-stage-melanoma-setting

BioNTech Biotechnology Uncategorized

BioNTech fades out further work with cancer vaccine prospect in late-stage melanoma setting

Oct 20, 2025

BioNTech won’t proceed with further development of its BNT111 cancer vaccine candidate in a specific...

biontech,-bms-tout-first-global-data-for-pd-l1xvegf-bispecific-in-small-cell-lung-cancer,-set-phase-3-dose

BioNTech Biotechnology Uncategorized

BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose

Sep 7, 2025

BioNTech and its new partner Bristol Myers Squibb have trotted out the first global data...

biontech-cuts-90-more-us-jobs-as-the-drugmaker-hones-pipeline-focus

BioNTech Biotechnology Uncategorized

BioNTech cuts 90 more US jobs as the drugmaker hones pipeline focus

Aug 5, 2025

As part of a “strategic alignment” of its pipeline, BioNTech is laying off 90 workers...